Back To Schedule
Monday, June 25 • 3:00pm - 4:00pm
#141: eSource: The Road to Real World Evidence – Are We There Yet?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-18-538-L04-P; CME 1.00; IACET 1.00; RN 1.00

The arrival of wearables and big data, felt like clinical research would change overnight. But has it? This session will consider a variety of real world sources, how they are/could change the way we do trials, and ask when will the real world vision will deliver.

Learning Objectives

Describe different forms of eSource, how data can be acquired. and what it could deliver; Discuss barriers, regulatory, process, technical – and methods to break them down; Identify how eSources may radically change our industry, for the better.


Jonathan Palmer


Daniel Rollings Karlin, DrMed, MA, FAPA

Matthew Moyer, MBA, MS, PMP

Jeremy Wyatt, MBA


Daniel Karlin

Head of Clinical, Informatics, and Regulatory Strategy, Pfizer Inc
Dan is the Head of Clinical, Informatics, and Regulatory Strategy for Digital Medicine and Pfizer Innovation Research Lab, where he manages strategy for multiple aspects of Pfizer’s collaborative digital measurement and endpoint development efforts. Dan is board certified in Psychiatry... Read More →
avatar for Matthew Moyer

Matthew Moyer

Director, Merck & Co., Inc.
Matt has 15 years of pharmaceutical development experience with Merck, and is Director of Clinical Supply Technology. He leads Merck’s clinical supply innovation efforts, incorporating new digital and enabling technologies to drive improved clinical trial execution, and more informed... Read More →
avatar for Jonathan Palmer

Jonathan Palmer

Senior Director, Product Strategy, Digital Trials, Oracle Health Sciences
Jonathan leads Product Strategy for Digital Trials within Oracle’s Health Sciences Global Business Unit. He is responsible for defining, and delivering, new innovative Digital/mHealth solutions. He has spent over 20 years within Oracle’s Clinical Trial business teams delivering... Read More →
avatar for Jeremy Wyatt

Jeremy Wyatt

CEO, ActiGraph, United States
Jeremy Wyatt is the CEO of ActiGraph, a leading provider of motion-sensing wearable technology solutions for pharmaceutical and academic research. With two decades of embedded hardware systems development and related cloud technology expertise, Jeremy has a uniquely well-rounded perspective... Read More →

Monday June 25, 2018 3:00pm - 4:00pm EDT
Room 257AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  02: ClinTrials -ClinOps, Session